Invitrogen, Readying Launch of microRNA Array, Puts ABI, GE Healthcare in Crosshairs | GenomeWeb

As Invitrogen prepares to launch a microRNA microarray platform, the company will take aim at an emerging market that has recently garnered quite a bit of attention from rivals in the BCW Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.